An update from Yandal Resources Ltd. ( ($AU:YRL) ) is now available. Yandal Resources Ltd has announced the extension of the Arrakis mineralised ...

Actor Nakoa-Wolf Momoa joins the production as Leto II in Dune: Part Three, while dad Jason Momoa comes back to the project as Duncan Idaho, which is a meaningful father-son moment, in Denis ...

In desert Arrakis, temperatures would reach 70°C or more, while in its ocean state, we put the highest recorded temperatures at about 45°C. That means the ocean Arrakis would be liveable even in ...

Dune: Awakening is a massive game that might have confused players at first. Despite officially avoiding the "MMO" label, the game was commonly described as such, which may have repelled some players ...

The planet Arrakis is the central setting in the first novel of Frank Herbert's Dune series. Here's what you need to know about the location. The post Everything You Need to Know About Arrakis ...

Funcom’s Arrakis has a weather system and it impacts the map destroying vehicles and potentially killing players. They’ll also have to deal with sandworms. Players can’t fight them.

Prepare to be transported back to the desert planet of Arrakis in the new “Dune: Part Two” trailer, where Paul Atreides (Timothée Chalamet) and Chani (Zendaya) are together at last.

Io is the most volcanically active world in the solar system, and it’s seriously volcanic. The whole moon’s surface is covered in sulfur, erupted out from its 400 volcanoes. The element itself ...

Arrakis is the desert planet in Dune, that is also known as Rakis. It is a harsh desert planet located on the far edge of the Old Imperium in the Canopus star system.

CEO Michael Gilman said Arrakis faced an “unbelievable amount of skepticism” when it got started around 2017. In an interview with the Business Journal, Gilman explains how the company charted ...

Clearly you can’t visit the sand planet of Arrakis and maybe you wouldn’t want to. It’s hot, it’s dry, and you can’t walk in a straight line without a sandworm coming and eating you up ...

Today, Arrakis is upping the ante with a $75 million series B financing that it hopes will begin moving some of its most advanced programs, mostly focused on cancer, into clinical testing.